Market Place
Sourcing Support
MBX Biosciences Plans Obesity Day Conference To Expand Portfolio
23 Apr 2026 //
GLOBENEWSWIRE
MBX Biosciences Reveals 2025 Financials And Corporate Updates
12 Mar 2026 //
GLOBENEWSWIRE
MBX Biosciences Appoints Karen Basbaum As Chief Business Officer
10 Mar 2026 //
GLOBENEWSWIRE
MBX Biosciences Joins March Investor Conference
23 Feb 2026 //
GLOBENEWSWIRE
MBX Biosciences Names Laurie Stelzer Audit Committee Chair
22 Jan 2026 //
GLOBENEWSWIRE
Mbx Biosciences Joins Stifel 2025 Virtual Cardiometabolic Forum
29 Sep 2025 //
GLOBENEWSWIRE
MBX Biosciences Initiates Phase 1 Trial for MBX 4291 in Obesity
04 Sep 2025 //
GLOBENEWSWIRE
MBX Biosciences Reports Q2 2025 Financial Results and Corporate
07 Aug 2025 //
GLOBENEWSWIRE
MBX Biosciences to Attend Investor Conferences
22 Apr 2025 //
GLOBENEWSWIRE
MBX Biosciences at 24th Annual Needham Virtual Healthcare Conf.
26 Mar 2025 //
GLOBENEWSWIRE
MBX Biosciences Reports Positive Phase 1 Results For MBX 1416
07 Jan 2025 //
GLOBENEWSWIRE
MBX Biosciences Announces Last Visit in MBX 1416 Ph 1 Trial
18 Nov 2024 //
GLOBENEWSWIRE
MBX Biosciences Presents Ph 2 Trial Design At ASBMR Meeting
30 Sep 2024 //
GLOBENEWSWIRE
MBX Biosciences Announces Pricing of Initial Public Offering
12 Sep 2024 //
GLOBENEWSWIRE
MBX Biosciences seeks up to $482.5 mln valuation in US IPO
09 Sep 2024 //
REUTERS
Peptide Biotech MBX Submits IPO Plans For Post-Labor Day Nasdaq Listing
26 Aug 2024 //
ENDPTS
MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
05 Feb 2024 //
GLOBENEWSWIRE
MBX Biosciences to Participate in Oppenheimer 34th Annual Conference
31 Jan 2024 //
GLOBENEWSWIRE
MBX Biosciences to Participate in 42nd Annual J.P. Morgan Healthcare Conference
20 Dec 2023 //
GLOBENEWSWIRE
MBX Bio to Participate in Piper Sandler 35th Annual Healthcare Conference
15 Nov 2023 //
GLOBENEWSWIRE
MBX Announces Appointment of Michelle Graham as Chief Human Resources Officer
01 Nov 2023 //
GLOBENEWSWIRE
MBX Biosciences Presents Positive Results from Phase 1 Study of MBX 2109
16 Oct 2023 //
GLOBENEWSWIRE
MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial of MBX 1416
09 Oct 2023 //
GLOBENEWSWIRE
MBX Biosciences to Showcase Results from Phase 1 Study of MBX 2109
03 Oct 2023 //
GLOBENEWSWIRE
MBX Bio Announces Positive Phase 1 Multiple Ascending Dose Data for MBX 2109
11 Sep 2023 //
GLOBENEWSWIRE
MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
29 Aug 2023 //
GLOBENEWSWIRE
MBX Biosciences Announces U.S. FDA Clearance of IND Application for MBX 1416
07 Aug 2023 //
GLOBENEWSWIRE
MBX Biosciences Appoints Steven J. Prestrelski as Chief Scientific Officer
10 Jul 2023 //
GLOBENEWSWIRE
MBX Biosciences to Participate in Jefferies Healthcare Conference
24 May 2023 //
GLOBENEWSWIRE
MBX Biosciences to Participate in May Investor Conferences
08 May 2023 //
GLOBENEWSWIRE
MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
10 Apr 2023 //
GLOBENEWSWIRE
MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 //
GLOBENEWSWIRE
